Nasiri M, Farhangi H, Badee Z, Ghasemi A, Golsorkhi M, Ravanshad Y, Azarfar A
While RF is found in approximately 75 to 80% of patients with RA, it is not entirely specific to the disease and can be found in healthy individuals or those with other rheumatic and nonrheumatic disorders (Shmerling & Greisen, 2025
Acknowledgements This work was partially supported by National Basic Research Program of China (973 Program
Moreover, the peptide has been tested in intranasal doses of up to 15mg, with researchers suggesting favorable safety and effectiveness when administered no more than twice weekly for 12 weeks [11]
Regular check-ins with your healthcare provider can help adjust dosage and ensure safety
Batf stabilizes Th17 cell development via impaired Stat5 recruitment of Ets1-Runx1 complexes